Home / Indicator library / Biotechnology and Medical Care / Stemcyte (4178) overview
Stemcyte (4178) stock overview
Valuation, financials, growth, ownership, events, dividends, models and adjusted prices for Stemcyte, on one pageStemcyte (4178) snapshot, key figures
Stemcyte (4178): where today sits in the past year
Current value against the 2025-07-31 to 2026-07-31 range, built from 65 frozen daily vintages.
Seven-dimension checkup for this ticker →
Valuation river
→Financial quality
→Revenue growth
→Ownership structure
→Events, last 90 days
→Yield river
→Valuation models
→Adjusted-price candles
→4178: common questions
What is 4178's price-to-book ratio?
4178's price-to-book ratio was 2.06x on 2026-08-03, taken as-is from the official public source.
How fast is 4178's revenue growing?
4178 reported 4.9% year-on-year monthly revenue growth for 2026-06, from the official monthly revenue filing.
Is 4178's price / book high or low right now?
4178's price / book is 2.06x, which is below its one-year median of 2.12x and sits at the 25th percentile of the 1.93–2.30x range observed over the last 65 snapshot dates. Each of those dates is a frozen point-in-time vintage, so the range contains no restated or back-filled values.
Other Biotechnology and Medical Care tickers
160 Taiwan-listed tickers sit in this sector. See the full Biotechnology and Medical Care table.